Lv4
450 积分 2021-02-22 加入
Molecular diagnosis of primary CNS lymphoma in 2024 using MYD88Leu265Pro and IL-10
7个月前
已完结
Post induction molecular MRD identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission
7个月前
已完结
MRD dynamics during maintenance for improved prognostication of 1280 patients with myeloma in the TOURMALINE-MM3 and -MM4 trials
7个月前
已完结
Three-Year Follow-Up Analysis of Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma (ZUMA-5)
7个月前
已完结
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia
7个月前
已完结
Real-World and Clinical Trial Outcomes in Large B-cell Lymphoma with Axicabtagene Ciloleucel Across Race and Ethnicity
7个月前
已关闭
Phase 3 randomized trial of mavorixafor, CXCR4 antagonist, in WHIM syndrome
7个月前
已关闭
Pediatric leukemia and maternal occupational exposure to anticancer drugs: the Japan Environment and Children’s Study
8个月前
已完结
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL
8个月前
已完结
A phase 2 trial of CD24Fc for prevention of graft-versus-host disease
8个月前
已关闭
皖公网安备34019202002308
